Trevi Therapeutics Inc (NASDAQ:TRVI)

1.13
Delayed Data
As of Nov 30
 +0.035 / +3.21%
Today’s Change
0.97
Today|||52-Week Range
3.50
-41.45%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Trevi Therapeutics Inc have a median target of 7.50, with a high estimate of 9.00 and a low estimate of 6.00. The median estimate represents a +563.72% increase from the last price of 1.13.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Trevi Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.11
Sales
$0.00
Reporting Date
Mar 20

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -35.42%
 
 
 
 
 
 
Growthannually 20.74%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.